Cangene chickenpox drug granted orphan status
14th Nov 2006, 06:12 GMT
Cangene Corporation's varicella zoster immune globulin, known as VariZIG, has received orphan drug designation from the FDA for immunization of patients who are at high risk of developing chickenpox.
Cangene chickenpox drug granted orphan status related news:
- ChemGenex's CML drug on fast-track — United Press International - Health Business
- Alexion's Soliris granted priority review — United Press International - Health Business
- Alexion Blood Disorder Treatment Granted Priority Review — RedOrbit News - Health
- SureScripts: SureScripts(R) Announces New Certification Status to Recognize Physician Software and Service Providers Most Committed to Healthcare Interoperability — Market Wire - Computers and Software
- Generex Biotechnology: First Metformin Gum Patent Granted to Generex Biotechnology — Market Wire - Pharmaceuticals and Biotech
- Cangene Corp Goes Live with Sparta Systems' TrackWise Quality and Compliance Mgmt Software — Bio-Technology News from StratCenter.com
- Alexion Gets Priority Review on Soliris — Bio-Technology News from StratCenter.com
- Frank Osei And Others Seek Floating Status — AllAfrica News: Ghana
- Ghana: Frank Osei And Others Seek Floating Status — AllAfrica News: Sport
- Mitchell granted the right to appeal his conviction — Scotsman.com News - Jodi Jones murder
Latest news from Pharmaceutical Business Review Latest News:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol
- ZymoGenetics, Serono present positive results for atacicept